Skip to main content

Month: August 2024

Jyske Realkredit’s auctions for the 1st October 2024

To Nasdaq Copenhagen A/S                                6th of August 2024Announcement no. 64/2024 Jyske Realkredit’s auctions for the 1st October 2024 Jyske Realkredit plans to carry out the auctions Monday 26th of August through Thursday 29th of August for loans in cover pool E. The refinancing amount and bonds to be offered are specified in the table below:  Open Close Alloc. Name ISIN Amount mill. LCRMonday 26 of August 09:30 10:00 10:05 1% JRK 1/10-2025 SDO (IT) DK0009414096 3750 mio. 1BTuesday 27 of August 09:30 10:00 10:05 1% JRK 1/10-2025 SDO (IT) DK0009414096 3750 mio. 1B  11:00 11:30 11:35 1% JRK 1/4-2027 SDO DK0009391534 1200 mio. 1BWednesday 28 of August 09:30 10:00 10:05 1% JRK 1/10-2025 SDO (IT) DK0009414096 3750 mio. 1B  11:00 11:30 11:35 1% JRK 1/4-2028 SDO DK0009393316 4000 mio. 1BThursday 29 of August 09:30 10:00 10:05 1%...

Continue reading

Update: Lakeside Holding Partners With Leading Global Social Media and E-Commerce Platform to Streamline Cross-Border Fulfillment

Enhancing Logistics Operations with Advanced API Integration Itasca, IL, Aug. 06, 2024 (GLOBE NEWSWIRE) — Lakeside Holding Limited (“Lakeside” or the “Company”) (Nasdaq: LSH), a U.S.-based integrated cross-border supply chain solution provider with a strategic focus on the Asian market operating under the brand American Bear Logistics (“ABL”), today announced a strategic agreement with one of the world’s most popular social media and e-commerce platforms (the “Platform”). This collaboration will provide sellers on the Platform with a comprehensive suite of customs brokerage services, including customs clearance and customs duty management. Technology-Driven Efficiency ABL’s partnership goes beyond traditional logistics services, powered by its cutting-edge technology and team of experts. The Company’s advanced API...

Continue reading

60 Degrees Pharmaceuticals, Inc. Announces 1:12 Reverse Stock Split

WASHINGTON, Aug. 06, 2024 (GLOBE NEWSWIRE) — 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, announced today that it will effect a 1-for-12 reverse stock split (“Reverse Stock Split”) of its common stock, par value $0.0001 per share (“Common Stock”). The Common Stock will continue to trade on The Nasdaq Capital Market under the existing symbol “SXTP” and will begin trading on a split-adjusted basis when the market opens on August 12, 2024. The new CUSIP number for the Common Stock following the Reverse Stock Split will be 83006G203. The Reverse Stock Split is primarily intended to bring the Company into compliance with The Nasdaq Stock Market LLC’s (“Nasdaq”) $1.00 minimum bid price requirement for maintaining its Nasdaq...

Continue reading

Novo Business Review

VANCOUVER, British Columbia, Aug. 06, 2024 (GLOBE NEWSWIRE) — HIGHLIGHTSExploration ramped up across Novo Resource’s (Novo or the Company) priority Pilbara targets in Q2 2024, with drilling programs running concurrently at Nunyerry North and the Becher Project (Becher) in the Egina Gold Camp. Drilling at Nunyerry North commenced in May 2024 and was completed in late July 2024 with over 3,200 m reverse circulation (RC) drilling to date. The program tests multiple new targets along strike of known mineralisation and down plunge of existing intercepts. Final assays expected mid- August. Follow-up aircore (AC) and RC drilling programs commenced at Novo’s flagship Becher Project by De Grey Mining (De Grey) with two drill rigs. Initial focus for these programs is on testing gold and base metal mineralisation at the priority Heckmair...

Continue reading

Spectaire Completes First Ever Carbon Credit Transaction Sourced from Measured1 Diesel Engine Emissions and Takes Carbon Credit Trading Platform AireCoreX Live; Announces NASDAQ Hearing Results

Targeting 10M+ diesel engines with emission mitigation technology Spectaire’s AireCore technology and Newly Launched AireCoreX trading platform can enable the creation of 100+ carbon credits per engine annually Similar carbon credits priced at over $100 per credit WATERTOWN, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) — AireCoreX Launch Spectaire Holdings Inc. (NASDAQ: SPEC) (“Spectaire” or the “Company”), a pioneer in environmental measurement technology, today announced the launch of its innovative carbon credit trading platform, www.AireCoreX.com, and the completion of the first-ever carbon credit transaction sourced directly from measured diesel engine emissions using the Company’s AireCore technology. This significant milestone positions Spectaire at the forefront of sustainable technology, leveraging its AireCore system to provide...

Continue reading

Tejon Ranch Co. Announces Second Quarter 2024 Financial Results

TEJON RANCH, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) — Tejon Ranch Co., or the Company, (NYSE:TRC), a diversified real estate development and agribusiness company, today announced financial results for the three and six-months ended June 30, 2024. “In the second quarter 2024, we continued our strategic efforts to unlock the value of our entitled land assets and grow our diversified cash flow streams for the Company. Terra Vista at Tejon, our first multi-family apartment community located in our Tejon Ranch Commerce Center, has seen significant progress with its development timeline and is expected to have leasable units available in the second quarter of 2025. Ultimately, Terra Vista at Tejon will include up to 495 units, highlighting our commitment to fostering economic growth in our retail and industrial assets, while we...

Continue reading

Sofwave Medical Reports Second Quarter and First Half 2024 Financial Results and Business Highlights

Second quarter revenue of $14.6M, +18% year-over-year growth; IFRS gross margin of 76.1% Second quarter pulse recurring revenue of $6.0M, +83% year-over-year growth First half revenue of $27.8M, +22% year-over-year growth, IFRS gross margin of 75.7% First half IFRS and Non-IFRS operating loss continues to narrow substantially and decreased YoY by 66% and 80%, respectively Sofwave continues to expect to achieve operating break-even in 2024SAN CLEMENTE, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) — Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, reported financial results for the second quarter and first half of fiscal year 2024, for the period ended June 30, 2024, and recent business highlights. Second Quarter and First Half Fiscal 2024 Financial...

Continue reading

Inozyme Pharma Reports Second Quarter 2024 Financial Results and Provides Business Highlights

– Complete enrollment in ENERGY 3, a pivotal trial of INZ-701 in pediatric patients with ENPP1 Deficiency, expected third quarter of 2024 – – Interim data from ENERGY 1, a Phase 1b trial of INZ-701 in infants with ENPP1 Deficiency, on track for fourth quarter of 2024 – – Interim data from SEAPORT 1, a Phase 1 trial of INZ-701 in patients with end-stage kidney disease receiving hemodialysis, on track for fourth quarter of 2024 – – Cash, cash equivalents, and short-term investments as of June 30, 2024, expected to fund operations into the fourth quarter of 2025 – BOSTON, Aug. 06, 2024 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage rare disease biopharmaceutical company developing innovative therapeutics for rare diseases that affect bone health and...

Continue reading

SciSparc’s Collaboration with Clearmind Medicine Continues to Bear Fruit With New Scientific Article Showing MEAI Potential as a Novel Weight Loss Drug

SciSparc has been collaborating with Clearmind Medicine to create effective treatments for obesity and metabolic syndrome by combining SciSparc’s Palmitoylethanolamide (PEA) with Clearmind’s MEAI TEL AVIV, Israel, Aug. 06, 2024 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (the “Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, today announced that a new article published by Baraghithy et al. on the promising results from a recent study on 5-methoxy-2-aminoindane (“MEAI”), Clearmind Medicine Inc’s (Nasdaq: CMND) (“Clearmind” or “Clearmind Medicine”) innovative psychoactive molecule, for combating obesity. The study was meticulously conducted by a team of experts led by...

Continue reading

Getty Images Announces Canva Partnership Renewal

A Media Snippet accompanying this announcement is available by clicking on this link. NEW YORK, Aug. 06, 2024 (GLOBE NEWSWIRE) — Getty Images (NYSE: GETY), a preeminent global visual content creator and marketplace, today announced the renewal of its partnership with Canva, the world’s all-in-one visual communication platform. The multi-year renewal will continue to provide Canva’s customers with access to millions of Getty Images’ award-winning creative image and video assets. The renewal also expands the partnership to support Canva’s work to develop responsibly trained generative AI tools, as part of Canva’s $200 million Content Fund. Getty Images has partnered with Canva since 2018, adding to the Canva content library with millions of high-quality images and videos available to license. “We are pleased to extend and deepen...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.